Kevin Komakech

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda”.

High prevalence of phenotypic pyrazinamide resistance and its association with pncA gene mutations in Mycobacterium tuberculosis isolates from Uganda

PLoS ONE(2020)10.1371/journal.pone.0232543

N/A

0DataRank · unranked

18 citations

Gerald Mboowa, Kevin Komakech, Derrick Semugenze, David Patrick Kateete, Willy Ssengooba +1 more

Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab173

N/A

0DataRank · unranked

6 citations

Jean de Dieu Iragena, Kevin Komakech, Iginitius Okello, Joanitah Nalunjogi, Winceslaus Katagira +6 more

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases(2021)10.1016/j.jctube.2021.100286

N/A

0DataRank · unranked

0 citations

Kevin Komakech, Sharon Namiiro, Henry Byabajungu, Joanitah Nalunjogi, Winceslaus Katagira +7 more

Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda

Research Square(2023)10.21203/rs.3.rs-3324330/v1

N/A

0DataRank · unranked

2 citations

Lydia Nakiyingi, A. Lenin Fred, Beatrice Achan, Moses Joloba, Bruce Kirenga +2 more

Effect of mixed Mycobacterium tuberculosis infection on rapid molecular diagnostics among patients starting MDR-TB treatment in Uganda

BMC Infectious Diseases(2024)10.1186/s12879-023-08968-5

N/A

0DataRank · unranked

12 citations

Lydia Nakiyingi, A. Lenin Fred, Beatrice Achan, Moses Joloba, Bruce Kirenga +2 more

Gut colonization of Enterococcus species is associated with COVID-19 disease in Uganda

medRxiv(2024)10.1101/2024.09.28.24314457

N/A

0DataRank · unranked

0 citations

David Patrick Kateete, Emmanuel Nasinghe, Rogers Kamulegeya, Christopher Lubega, Monica Mbabazi +25 more

Enterococcus and Eggerthella species are enriched in the gut microbiomes of COVID-19 cases in Uganda

Gut Pathogens(2025)10.1186/s13099-025-00678-4

N/A

0DataRank · unranked

2 citations

David Patrick Kateete, Emmanuel Nasinghe, Rogers Kamulegeya, Christopher Lubega, Monica Mbabazi +25 more

Performance evaluation of alternative bacteriological measures of response to MDR-TB therapy during the initial 16 weeks of treatment

Research Square(2025)10.21203/rs.3.rs-5834681/v1

N/A

0DataRank · unranked

0 citations

Emmanuel Musisi, Derrick Semugenze, Kevin Komakech, Moses Ndema, Christine Sekaggya‐Wiltshire +7 more

Deciphering rifampicin resistance among tuberculosis patients who have trace results on Xpert MTB/RIF ultra assay

medRxiv(2025)10.1101/2025.06.13.25329610

N/A

0DataRank · unranked

0 citations

Derrick Semugenze, Francis Okello, James Sserubiri, Kevin Komakech, Benon Asiimwe +2 more